Dr Nick Camp is a medicinal chemist with 28 years drug discovery experience gained within major pharma, biotech and CROs. He is a highly motivated drug hunter and co-inventor of several clinical candidates. During his project management role at WuXi AppTec, Nick worked with multiple clients across a range of therapeutic areas and modalities. As a group leader at Eli Lilly he drove the diversification of the UK chemistry group resulting in a significant increase in portfolio deliverables for the department, including multiple clinical candidates. During his time in biotech, Nick was involved in a successful collaboration that delivered the Factor Xa clinical compound LY517717 involving one of the earliest fragment based design approaches. He has extensive project leadership experience having worked across all phases of pre-clinical drug discovery and is recognised for developing future leaders. Nick helped to enhance links between Academia and Pharma through his role as Entrepreneur in Residence at the University of Southampton. He has a good track record of publications including, 15 scientific publications and 15 patents.

​

Expertise: Small Molecule Drug Discovery, Medicinal Chemistry Strategies, Design and SAR, Project Leadership, Project Management, Enzyme inhibitors, SBDD, FBDD, Issue-driven and Multi-dimensional SARs, Virtual Libraries, Disruptive Technologies, Lead Optimisation, Hit to Lead, Early Portfolio, Target Validation, Neuroscience.